International congress of Immunology IUIS, July, in Montr‰al, Canada.
Federation of clinical Immunology Societies FOCIS, July, , Montr‰al,
The th conference on Transplantation and clinical Immunology, , Lyon,
International Meeting Collaboration
Stem Cell Network, Toronto, November , Poster session examinator.
, Member associate at Stem Cell Network.
Member of ACFAS scientific association.
Targeting additional costimulatory pathways: a subtle role for CD. Dumont C,
Deas O, H. C, Durrbach A, Hirsch F, Charpentier B, Senik A. Transplant Proc
Cytokine expression in peripheral CD+ T cells from tolerant renal allograft
recipients. H. C, Rouleau M, Hirsch F, Durrbach A, Legendre C, Senik A,
Charpentier B. Transplant Proc. Mar; :.
Peripheral blood T cells generated after allogeneic bone marrow
transplantation: lower levels of bcl protein and enhanced sensitivity to
spontaneous and CDmediated apoptosis in vitro. Abrogation of the apoptotic
phenotype coincides with the recovery of normal naive/primed Tcell profiles.
H. NC, Deas O, Rouleau M, Durrbach A, Charpentier B, Beaujean F, Vernant
JP, Senik A. Blood. Sep ; :.
Pattern of cytokine expression in circulation CD+ T cells from longterm
renal allograft recipients. H. C, Leroy E, Rouleau M, Fornairon S, Metivier
D, Hirsch F, Kroemer G, Legendre C, Senik A, Charpentier B. Transpl Immunol.
Caspaseindependent cell death induced by antiCD or staurosporine in
activated human peripheral T lymphocytes. Deas O, Dumont C, MacFarlane M,
Rouleau M, H. C, Harper F, Hirsch F, Charpentier B, Cohen GM, Senik A. J
Immunol. Oct ; :.
Potent apoptotic signaling and subsequent unresponsiveness induced by a single
CD mAb BTI in activated human peripheral T cells. Dumont C, Deas O,
Mollereau B, H. C, GiovinoBarry V, Bernard A, Hirsch F, Charpentier B,
Senik A. J Immunol. Apr ; :.
Elimination of human acute myeloid leukemia AML cells using an antiCD
maytansinoid immunoconjugate. N.C. H., F. Larochelle, B. Lutz, J. Lambert,
J. H‰bert, W. Blattler, D. C. Roy. Oral presentation and poster presentation
at the th Annual Scientific Meeting of the International Society for
Experimental Hematology, September in Minneapolis, USA.
Novel antiCD immunoconjugate demonstrating in vitro and in vivo activity
against human acute myeloid leukemia AML cells. Nadia C. H., Fannie
Larochelle, Bob Lutz, John Lambert, Walter Blattler, Denis Claude Roy. Poster
presentation at the American Association for Cancer Research annual